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Mitotic phosphorylation of Pex14p regulates
peroxisomal import machinery
Koichiro Yamashita1*, Shigehiko Tamura2*, Masanori Honsho3,4, Hiroto Yada1, Yuichi Yagita3, Hidetaka Kosako5, and Yukio Fujiki3,4
Peroxisomal matrix proteins are imported into peroxisomes via membrane-bound docking/translocation machinery. One
central component of this machinery is Pex14p, a peroxisomal membrane protein involved in the docking of Pex5p, the receptor
for peroxisome targeting signal type 1 (PTS1). Studies in several yeast species have shown that Pex14p is phosphorylated
in vivo, whereas no function has been assigned to Pex14p phosphorylation in yeast and mammalian cells. Here, we
investigated peroxisomal protein import and its dynamics in mitotic mammalian cells. In mitotically arrested cells, Pex14p is
phosphorylated at Ser-232, resulting in a lower import efficiency of catalase, but not the majority of proteins including
canonical PTS1 proteins. Conformational change induced by the mitotic phosphorylation of Pex14p more likely increases
homomeric interacting affinity and suppresses topological change of its N-terminal part, thereby giving rise to the retardation
of Pex5p export in mitotic cells. Taken together, these data show that mitotic phosphorylation of Pex14p and consequent
suppression of catalase import are a mechanism of protecting DNA upon nuclear envelope breakdown at mitosis.
Introduction
Peroxisomes are ubiquitous, single-membrane-bounded organ-
elles with a large variety of metabolic functions, such as
β-oxidation of very-long-chain fatty acids and biosynthesis of
plasmalogens (Fujiki, 1997; Lazarow and Moser, 1995). The
peroxisome’s metabolism depends on the import of nuclear
gene-encoded proteins from the cytosol into each peroxisome
(Lazarow and Fujiki, 1985). The majority of matrix proteins are
destined for import into the peroxisomal matrix by a distinct
dynamic system involving peroxins such as Pex1p, Pex2p,
Pex5p, Pex6p, Pex7p, Pex10p, Pex12p, Pex13p, Pex14p, and
Pex26p (Fujiki et al., 2006; Platta and Erdmann, 2007). The
matrix proteins harbor the peroxisomal targeting tripeptide
signal 1 (PTS1) at the C terminus or cleavable nonapeptide pre-
sequence PTS2 at the N terminus (Fujiki, 1997). These targeting
signals are specifically recognized by the PTS1 receptor, Pex5p,
and the PTS2 receptor, Pex7p (Fodor et al., 2015; Gatto et al.,
2000; Otera et al., 2000, 2002). The soluble receptor–cargo
protein complexes dock with Pex14p, the membrane peroxin of
peroxisomal matrix protein importomer (Dias et al., 2017). After
releasing the cargo into the peroxisomal matrix, Pex5p recycles
to the cytosol through a process requiring monoubiquitination
of a conserved, cytosolically exposed cysteine residue at the
N-terminal region (Platta et al., 2016). The Pex5p recycling step
requires ATP hydrolysis catalyzed by the AAA ATPases, Pex1p
and Pex6p, and their membrane-anchoring peroxin, Pex26p
(Matsumoto et al., 2003; Miyata and Fujiki, 2005; Platta et al.,
2005; Tamura et al., 1998). Pex26p interacts with Pex14p to form
a recycling complex with Pex5p, Pex6p, and Pex1p (Tamura
et al., 2014). The Pex1p–Pex6p complex interacts with mono-
ubiquitinated Pex5p to unfold the Pex5p polypeptide chain
during the ATP-dependent extraction step from the transloca-
tion machinery (Pedrosa et al., 2018; Schwerter et al., 2018).
The membrane-anchored peroxin Pex14p has been described
as a central component of the translocation machinery for per-
oxisomal matrix proteins (Dias et al., 2017). A conserved domain
of Pex14p comprising residues 21–70 interacts with Pex5p,
Pex13p, and Pex19p (Neufeld et al., 2009; Su et al., 2009). Pex14p
forms a homodimer by the coiled-coil domain or a larger oli-
gomer by GXXXG and AXXXA motifs in the transmembrane
domain (Itoh and Fujiki, 2006).
Pex14p and Pex11p are a target for phosphorylation in yeast.
In regard to Pex11p, cyclin-dependent protein kinase Pho85 is
involved in the phosphorylation of Pex11p, negatively regulating
the transfer of metabolites across peroxisomal membrane in
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yeast, Saccharomyces cerevisiae (Knoblach and Rachubinski, 2010;
Mindthoff et al., 2016). Moreover, in Hansenula polymorpha
(Tanaka et al., 2012), Pichia pastoris (Johnson et al., 2001), and S.
cerevisiae (Oeljeklaus et al., 2016), Pex14p was detected in a
phosphorylated and an unphosphorylated state. Additionally,
although a lot of data on proteomics analysis show the phos-
phorylation sites of mammalian Pex14p, the role of Pex14p
phosphorylation remains obscure.
On the other hand, the functions of protein import/traffick-
ing in other organelles such as mitochondria or ER are regulated
by the phosphorylation of these organelle assembly proteins in
mitosis in many species, including yeast and mammalian cells
(Harbauer et al., 2014; Olsen et al., 2010; Salazar-Roa and Ma-
lumbres, 2017; Shiota et al., 2015; Taguchi et al., 2007; Wang
et al., 2014; Yeong, 2013). Protein trafficking from ER to Golgi
apparatus is down-regulated by the phosphorylation of p47 with
cyclin-dependent kinase 1 (CDK1) in mitosis in mammalian cells
(Yeong, 2013). In S. cerevisiae, Tom6, amember of the translocase
of the outer membrane (TOM) family, is phosphorylated in
mitosis, resulting in up-regulation of the respiratory activity in
mitochondria (Harbauer et al., 2014). Until now, the regulation
of peroxisomal matrix protein import in mitosis has not been
elucidated. Here we show that mammalian Pex14p is phos-
phorylated in mitosis, resulting in down-regulation of peroxi-
somal matrix protein import.
Results
Pex14p is phosphorylated in mitosis
It has been reported that Pex14p is phosphorylated in P. pastoris,
H. polymorpha, and S. cerevisiae (Johnson et al., 2001; Oeljeklaus
et al., 2016; Tanaka et al., 2012). According to at least two data-
bases (PhosphoGRID, PhosphoSitePlus), yeast and mammalian
Pex14p is also phosphorylated, whereas details of physiological
functions of the phosphorylation are not yet known. Cell cycle–
dependent regulation of mitochondrial components is observed in
a few cases, including activation of the fission protein Drp1 and
respiratory complex I (Harbauer et al., 2014; Taguchi et al., 2007;
Wang et al., 2014).
In this study, we investigated whether Pex14p is phosphor-
ylated in the mammalian cells HeLa and CHO-K1. One distinct
slow-migrating band of Pex14p was detected in HeLa and CHO-
K1 cells by Phos-tag PAGE, suggesting that Pex14p is partially
phosphorylated in vivo (Fig. 1 A, lane 1). The results raised
the possibility that Pex14p is phosphorylated in any specific
cell events, including the cell cycle. HeLa and CHO-K1 cells
were synchronized in mitosis with nocodazole, a microtubule-
disrupting agent, and separated from adherent interphase cells
by mitotic shake-off. In Phos-tag PAGE analysis, the slow-
migrating Pex14p band was significantly increased in mitotic-
phase cells compared with interphase cells (Fig. 1 A, lanes 2 and
3). An elevated level of phosphorylated histone (p-histone) in-
dicated adequate separation of mitotic-phase cells. Upon treat-
ment with λ protein phosphatase, the slow-migrating band was
diminished in unsynchronized and mitotic cells (Fig. 1 A, lanes
4–6), suggesting that Pex14p is phosphorylated specifically in
mitotic but not interphase cells. Various signal transduction
pathways might be involved in the Pex14p phosphorylation.
Next, we examined whether any other peroxins required for
peroxisomal protein import are phosphorylated in mitosis.
In mitotically arrested and interphase HeLa cells, no slow-
migrating Pex13p was detected in Phos-tag PAGE analysis,
while a part of Pex5p was likely to be phosphorylated, but in-
dependently of cell cycle progression. In mitotically arrested
HeLa cells, most of the Pex14p was phosphorylated (Fig. 1 B),
suggesting that the phosphorylation of Pex14p in the convergent
import machinery is more likely involved in the regulation of
peroxisomal protein translocation in mitotic cells.
Serine 232 of human Pex14p is phosphorylated in mitotic cells
To identify mitotic phosphorylation sites in human Pex14p, ly-
sates from nocodazole-arrested and nontreated HeLa cells were
subjected to immunoprecipitation with anti-Pex14p antibody
followed by tryptic digestion and phosphopeptide enrichment
by TiO2. Liquid chromatography (LC)–tandem mass spectrom-
etry (MS/MS) analysis showed that Pex14p phosphorylation at
Ser232 was detected only in mitotic phase, suggesting that
Ser232 is a phosphorylation site of endogenous human Pex14p in
nocodazole-arrested, but not in nontreated, HeLa cells (Fig. 2, A
and B). On the other hand, not only Ser232 but also Ser334 of
Flag-tagged rat Pex14p transiently expressed in pex14 HeLa cells
were also identified as mitotic phosphorylation sites (Fig. 2, A
and C). A mitotic phosphorylation site of human Pex14p, Ser232,
was highly conserved between vertebrates, while the phospho-
rylation site of rat Pex14p, Ser334, was partially conserved
(Fig. 2 D). These two serine residues are not conserved in yeast.
These results suggest that Ser232 can be more important for
mitotic phosphorylation and the functional regulation of Pex14p.
To confirm whether Ser232 and Ser334 of rat Pex14p are
phosphorylated, these two sites were substituted for alanine,
termed S232A and S334A, and the mitotic Pex14p was analyzed
by Phos-tag PAGE analysis (Fig. 2 E). Pex14p-S232Awas strongly
suppressed in phosphorylation of Pex14p in mitotic HeLa cells,
whereas Pex14p-S334A showed little effect on the mitotic
phosphorylation of Pex14p. In addition, mutation of Ser232 to
Ala appeared to induce mitotic phosphorylation of rat Pex14p at
Ser247 (Fig. S1, lanes 4, 6, and 16). This residue of endogenous
Pex14p was not phosphorylated in the mitotic HeLa cells, as
assessed by LC-MS analysis. Ectopic transient expression of rat
Pex14p harboring Ser232Ala appeared to cause an artifactual
phosphorylation of Ser247 in mitotic cells. Ser232 residue of
Pex14p comprises the Ser-Pro consensus sequence for phos-
phorylation by CDKs (Errico et al., 2010). Therefore, we veri-
fied which kinase is involved in the mitotic phosphorylation of
Pex14p.
In mitosis, CDK1 phosphorylates various downstream pro-
teins, thereby regulating mitosis-specific events. However,
CDK1 should be inactivated to exit frommitosis, which could be
achieved by protein phosphatases (Hunt, 2013). It is reasonable
to suspect that mitosis-specific Pex14p phosphorylation is
regulated by CDK1, because Pex14p is phosphorylated remark-
ably in mitosis rather than interphase. Thus, we investigated
whether CDK1 is involved in Pex14p phosphorylation by mak-
ing use of a CDK1 inhibitor, RO-3306. Mitotic HeLa cells were
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incubated for 5–60 min with RO-3306 or control DMSO, and
cell lysates were analyzed by Phos-tag PAGE. The slow-
migrating phosphorylated Pex14p was no longer detectable,
but not degraded, at least within 1-h treatment with RO-3306
(Fig. 2 F), suggesting that CDK1 is responsible for Pex14p
phosphorylation. Because inhibition of CDK1 results in mitotic
exit via activation of protein phosphatases (Wu et al., 2009),
Pex14p is likely dephosphorylated by protein phosphatases that
are activated at mitotic exit (Fig. 2 F, left panels). In addition,
the phosphorylated Pex14p appeared to be stepwise dephos-
phorylated in the presence of RO-3306. Thus, it is likely that the
inhibition of CDK1 with RO-3306 gives rise to dephosphoryla-
tion at Ser232 and subsequent phosphorylation at Ser247.
We next evaluated the knockdown effect of CDK1 on mitotic
phosphorylation of Pex14p. Introduction of CDK1-specific siRNA
knocked down >90% of CDK1 (Fig. 2 G). CDK1 down-regulation
clearly decreased to a barely detectable level of the slow-
migrating Pex14p band in Phos-tag PAGE analysis, in contrast
to the mock-treated cells (Fig. 2 G, top panel). Taken together,
these findings suggested that CDK1 is responsible for the mi-
totic phosphorylation of Pex14p.
Phosphomimetic mutation of Pex14p suppresses peroxisomal
matrix protein import
Subcellular organelles receive mitosis-specific regulation. CDK1-
mediated phosphorylation of mitochondrial proteins promotes
their efficient protein import and thereby up-regulation of
respiration, while the secretory pathway, including that from
ER to Golgi apparatus, is down-regulated by CDK1 (Wang et al.,
2014; Yeong, 2013). However, the regulation of peroxisomes
in mitosis remains unknown. We next investigated mitosis-
specific regulation on peroxisomal function by generating rat
Pex14p mutants in which S232 and S334 were substituted by
Asp to mimic phosphorylation, termed S232D and S334D.
Peroxisome-restoring activity of S232D and a nonphosphorylation
form, S232A, was verified by transient expression in the pex14
HeLa cell line. In cells expressing WT PEX14 or S232A, numerous
PTS1-positive punctate structures, peroxisomes, were detected,
indicating restoration of the impaired PTS1 protein import (Fig. 3
A, two-row upper panels). By contrast, Pex14p-S232D showed
∼70% activity in the PTS1 protein import assay (Fig. 3, A [upper
panel] and Fig. 3 B). Moreover, catalase-positive peroxisomes
were very weakly detected in the cells transfected with S232D,
compared with those with PEX14 and S232A (Fig. 3 A [two-row
lower panels] and Fig. 3 B). The efficiency of catalase import
wasmuch lower than that of PTS1 import in the S232D-expressing
cells. The difference in the import efficiency likely reflects the fact
that Pex5p-catalase interaction is weaker than Pex5p binding to
PTS1 (Maynard et al., 2004). With respect to Pex14pS334D, per-
oxisomal protein import was not suppressed (Fig. 3, A and B).
Moreover, the import efficiency of a dual mutant Pex14pS232D/
S334D was similar to that of S232D (Fig. S2), suggesting that S232
is an important phosphorylation site in the regulation of peroxi-
somal protein import during mitosis. Taken together, these data
show that phosphomimeticmutation of Pex14p, S232D, suppresses
peroxisomal protein import, i.e., down-regulation in mitosis.
To confirm this finding, we performed EGFP-PTS1 targeting
assay using semi-intact HeLa cells that had been permeabilized
with digitonin (Mukai et al., 2019). Cell staining at different
stages of the cell cycle, prometaphase and interphase, repre-
sented a known pattern of mitotic spindle and DNA (Fig. 3 C,
right panels). The shorter isoform of PTS1-receptor Pex5p,
designated Pex5pS (Otera et al., 2002), was used in semi-intact
cell import assays. After incubation of the semi-intact cells with
the cytosol fraction containing recombinant EGFP-PTS1 and
Pex5pS, EGFP-PTS1 was detected in a manner superimposable
on Pex14p in interface cells (Fig. 3 C, right top panels, asterisks).
By contrast, EGFP-PTS1 was not transported to peroxisomes in
mitotic cells (Fig. 3 C, right top and middle panels, arrowheads).
However, peroxisomal targeting of EGFP-PTS1 was restored in
mitotic cells by treatment with λ phosphatase before the incu-
bation of EGFP-PTS1 and Pex5pS-containing solution (Fig. 3 C,
right middle and bottom panels). Similar observations were
obtained with most other cells (not depicted). Therefore, it is
Figure 1. Pex14p is phosphorylated in mitosis. (A) HeLa and CHO-K1 cells at mitotic phase (M) and interphase (I) and nontreated cells (–) were lysed,
treated with (+) or without (–) λ phosphatase, and analyzed by Phos-tag PAGE or SDS-PAGE followed by immunoblotting with anti-Pex14p antibody.
Phosphorylated (p) histone H3, mitotic marker. (B) Lysates of HeLa cells at I and M were analyzed by Phos-tag PAGE (upper panels) or SDS-PAGE (lower
panels) followed by immunoblotting with indicated antibodies. Open arrowheads indicate respective proteins; dots indicate a slow-migrating band.
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Figure 2. Mitotic phosphorylation of Pex14p. (A) Schematic representation of full-length human Pex14p with mitotic phosphorylation sites, S232 and S335.
Light gray box, Pex5p-binding domain; black box, transmembrane domain; dark gray box, coiled-coil domain. (B) MS analysis of phosphorylated Pex14p in
Yamashita et al. Journal of Cell Biology 4 of 15




 http://rupress.org/jcb/article-pdf/219/10/e202001003/1048951/jcb_202001003.pdf by Tokushim
a U
niversity Kuram
oto user on 13 April 2021
likely that the mitotic phosphorylation of Pex14p is responsible
for the suppression of peroxisomal protein import.
Pex5p binding to Pex14p is not altered in mitosis
As described above, we showed that phosphorylation of Pex14p
suppressed catalase and PTS1 import in mitotic cells (Fig. 3, A
and B). Pex14p acts as an initial docking factor of Pex5p, the
cytosolic receptor of PTS1 proteins. Next, we examined whether
such phosphorylation influences the interaction of Pex14p with
Pex5p. FLAG-Pex14p, S232A, or S232D was expressed in pex14
HeLa cells. Cell lysates of these transformants were analyzed by
immunoprecipitation assay with anti-FLAG antibody. Approxi-
mately the same level of endogenous Pex5p was coimmuno-
precipitated with FLAG-Pex14p, S232A, and S232D (Fig. 4 A).
Furthermore, we performed immunoprecipitation studies using
the lysates of HeLa cells at mitosis and interphase. Pex5p was
almost equally coimmunoprecipitated with Pex14p from the
mitotic-phase and interphase cells with the antibody specific for
the N-terminal part of Pex14p, Pex14pN, indicating that both
phosphorylated and unphosphorylated Pex14p are equally
competent to interact with Pex5p (Fig. 4 B).
Pex5p is imported into peroxisomes in interphase and
mitotic cells
To assess whether Pex5p import into peroxisomes is altered in
mitotic cells, we performed in vitro Pex5p import assays using
35S-labeled Pex5pL, a longer isoform of Pex5p. With postnuclear
supernatant (PNS) fractions each from interphase and mitotic
HeLa cells, [35S]Pex5pL was detected in both organelle fractions,
suggesting that [35S]Pex5pL was imported into peroxisomes
(Miyata and Fujiki, 2005) in mitosis as in interphase as assessed
by proteinase K resistance (Fig. 5 A, top panel, lanes 2 and 5,
solid arrowhead). A partially cleaved form of protease-resistant
[35S]Pex5pL was also detected in the organelle fraction from
interphase cells (Fig. 5 A, top panel, lane 2, open arrowhead),
likely representing [35S]Pex5pL locating in the peroxisomal
membrane and partly accessible to the protease (Miyata and
Fujiki, 2005). This result suggests that a part of Pex5p in per-
oxisomes is exposed to cytosol. The N-terminal region of Pex5p,
which is accessible to monoubiquitination leading to Pex5p re-
lease to the cytosol by Pex1p and Pex6p, is exposed to the cytosol,
consistent with the finding that the N-terminal region of Pex5p
is partially digested with proteinase K (Dias et al., 2017; Gouveia
et al., 2003; Pedrosa et al., 2018). In the organelle fraction from
mitotic cells, however, the partially cleaved [35S]Pex5pL was not
detectable, suggesting that a part of [35S]Pex5pL was not ex-
posed to the cytosol (Fig. 5 A, top panel, lane 5, solid arrowhead).
Imported Pex5p was not cleaved with proteinase K in mitosis,
suggesting that Pex5p is imported into and retained in perox-
isomes in the mitotic phase of the cell cycle. These results raise
the question of whether the step of Pex5p recycling is sup-
pressed in mitosis.
Pex5p export is suppressed in mitotic cells
Next, we investigated whether Pex5p is exported from perox-
isomes in mitotic cells. The export reaction mixtures containing
[35S]Pex5pL-imported organelle fraction (Fig. 5 A, lanes 1 and 4)
were incubated at 26°C for 30 min and separated into organelle
pellet (P) and cytosolic supernatant (S) fractions. [35S]Pex5pL
was detected in the S fraction with concomitant decrease of [35S]
Pex5pL in the P fraction from interphase cells, suggesting that
Pex5p was exported from peroxisomes, whereas [35S]Pex5pL
export was barely detected in the case of mitotic cells (Fig. 5 B,
top panel, lanes 2 and 4). [35S]Pex5pL in S and P fractions was
quantified to verify the Pex5p export (Fig. 5 C). The organelle
and cytosolic fractions were separated and verified for phos-
phorylation of Pex14p and Pex14p levels by Phos-tag PAGE and
SDS-PAGE, both followed by immunoblotting (Fig. 5 B, middle
and bottom panels). These results suggested that Pex5p export to
the cytosol is suppressed in mitosis, although Pex5p is normally
imported into peroxisomes (Fig. 5 C). Taken together, these data
show that the N-terminal region of Pex5p is not exposed to the
cytosol in mitosis, and probably the Pex5p structure is not al-
tered for Cys monoubiquitination, thereby resulting in inhibi-
tion of the interaction between Pex1p/Pex6p and Ub-Pex5p
through ubiquitin moiety (Pedrosa et al., 2018; Schwerter et al.,
2018). In mitosis, Pex5p export from peroxisomes is likely
suppressed by the mitotic phosphorylation of Pex14p.
Pex14p phosphorylation enhances its dimerization via the
coiled-coil domain
The coiled-coil domain is mainly responsible for homodimeri-
zation of Pex14p (Fransen et al., 2002; Itoh and Fujiki, 2006). In
this study, we investigated whether mitotic phosphorylation
influences the homomeric interaction of Pex14p and alters per-
oxisomal import of matrix proteins. The efficiency of homo-
meric interaction was evaluated with FLAG- or His-tagged
full-length Pex14p and respective variants harboring S232A
mitotic HeLa cells. HeLa cells were treated for 12–18 h with 50 ng/ml nocodazole and collected by mitotic shake-off. Adherent cells after shake-off were
collected as interphase cells. Endogenous Pex14p in mitotic and interphase HeLa cells was immunoprecipitated with anti-Pex14p antibody followed by tryptic
digestion and phosphopeptide enrichment by TiO2. Phosphorylation of Ser232 was demonstrated by the MS/MS spectrum of the 568.2641 ion from mitotic
cells. (C) FLAG-tagged rat Ptex14p in mitotic and interphase pex14 HeLa cells was immunoprecipitated with anti-FLAG antibody followed by tryptic digestion.
Phosphorylation of Ser334 was demonstrated by the MS/MS spectrum of the 1075.42861 ion from mitotic cells. (D) Multiple alignments of the region en-
compassing mitotic phosphorylation sites in Pex14p are shown. Yellow box indicates conserved Ser/Thr. Rn, Rattus norvegicus (rat);Mm,Mus musculus (mouse);
Hs, Homo sapiens (human); Gg, Gallus gallus (chicken); Xt, Xenopus tropicalis (frog); Dr, Danio rerio (zebrafish). (E) WT Pex14p and its mutants each harboring
S232A, S334A, and S232A plus S334A were separately expressed in pex14HeLa cells. Mitotic-phase and interphase cells were separated and analyzed by Phos-
tag PAGE or SDS-PAGE, followed by immunoblotting with anti-Pex14p antibody. GAPDH, loading control. (F)Mitotic HeLa cells arrested with nocodazole were
treated for 5–60 min with CDK1 inhibitor RO-3306 or DMSO. Respective cell lysates were analyzed by Phos-tag PAGE (top panels) or SDS-PAGE followed by
immunoblotting with indicated antibodies. I, cell lysate from interphase cells. (G) HeLa cells were treated for 72 h with control siRNA (–) or CDK1 siRNA (+).
Lysates of nocodazole-treated HeLa cells were analyzed by Phos-tag PAGE (top panel) or SDS-PAGE followed by immunoblotting with antibodies indicated on
the right. β-Tubulin, loading control.
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Figure 3. Peroxisomal protein import in mitotic HeLa cells. (A) Morphological analysis of phosphomimetic mutants of Pex14p. pex14 HeLa cells each
expressing mock (a–d), FLAG-Pex14p WT (e–h), S232A (i–l), S232D (m–p), and S334D (q–t) were fixed and visualized by staining with indicated antibodies 24 h
after transfection. Scale bar, 5 µm. (B) Import efficiency is represented as percentages of PTS1- or catalase-discernible cells in Pex14p-positive cells. n = 6.
Statistical significance was verified by ANOVA and post hoc Dunnett’s test, and the significance is presented by asterisk (*, P < 0.001). Error bars show SEM.
Yamashita et al. Journal of Cell Biology 6 of 15




 http://rupress.org/jcb/article-pdf/219/10/e202001003/1048951/jcb_202001003.pdf by Tokushim
a U
niversity Kuram
oto user on 13 April 2021
(SA) or S232D (SD) mutations (Fig. 6 A). FLAG- and His-tagged
Pex14p or the mutants were coexpressed in pex14HeLa cells and
verified for homointeraction by coimmunoprecipitation assay
with anti-FLAG antibody. Nearly an equal amount of WT and
S232A- and S232D-mutated His-Pex14p was recovered in the
fractions bound to respective FLAG-Pex14p variants, suggesting
that SA and SD mutations did not alter the efficiency of homo-
meric interaction (Fig. 6 B). Next, N-terminally truncated FLAG-
or HA-tagged Pex14p(156–376) with or without S232 mutations
were likewise assessed for homomeric interaction as in Fig. 6 B.
HA-Pex14p(156–376) variants recovered in the fractions bound
to FLAG-Pex14p(156–376) were analyzed. Interestingly, HA-
Pex14p(156–376)SA was coimmunoprecipitated with FLAG-
Pex14p(156–376)SA at a level similar to that noted with WT
Pex14p(156–376), whereas the recovery of HA-Pex14p(156–376)
SD by immunoprecipitation with FLAG-Pex14p(156–376)SD was
higher, suggesting that phosphomimetic mutation enhances homo-
interaction between HA- and FLAG-tagged Pex14p(156–376) (Fig. 6
C). Taken together, these data show that the effect of phosphorylation
is likely restricted to the region proximal to S232 of Pex14p.
Next, we assessed the effect of phosphomimetic mutation
on homo-oligomerization of Pex14p(156–376) by blue native
PAGE (BN-PAGE) analysis. FLAG-Pex14p(156–376) was de-
tected as a homo-oligomer, consistent with the results in the
coimmunoprecipitation studies and our earlier report
(Fig. 6 D; Itoh and Fujiki, 2006; Fransen et al., 2002).
Moreover, homo-oligomerization was stabilized by phosphomi-
metic mutation of FLAG-Pex14p(156–376)SD. Quantified data
showed that the formation of SD mutant homo-oligomer was
increased ∼1.5-fold compared with that of WT or SA mutant
(Fig. 6 D, right panel). Moreover, another N-terminally truncated
Pex14p variant, FLAG-Pex14p(200–376), was also competent to
form homo-oligomer despite lacking the coiled-coil domain
(Fig. 6 E). It is noteworthy that the homo-oligomer of SD mutant
migrated slightly faster than that of WT or SA mutant, where
these homo-oligomers were detected at a similar level (Fig. 6 E).
Phosphorylation at S232 likely modulates Pex14p homointer-
action by converting the homo-oligomer to a more compact
conformation. This conformational change of homo-oligomer
was more readily observed upon deletion of a coiled-coil do-
main. Taken together, these data show that it is more likely that
the phosphorylation at S232 enhances the homomeric interac-
tion and stabilizes the homo-oligomer of Pex14p C-terminal part.
These results raised the question of whether Pex14p changes
domain structure or membrane topology in response to the
phosphorylation at S232. Therefore, we used the limited prote-
olysis method to assess any conformational changes of Pex14p
induced by phosphorylation at S232. PNS fractions from pex14
HeLa cells expressing WT, SA, and SD mutants of FLAG-
Pex14p(156–376) were treated with various concentrations of
proteinase K. Upon proteinase K treatment, WT and SA mutants
of FLAG-Pex14p(156–376) resulted in several smaller-mass
(C) EGFP-PTS1 import assay was performed with semipermeabilized HeLa cells. Left: Purified recombinant proteins, EGFP-PTS1 (0.5 µg) and Pex5pS (2 µg),
were verified by SDS-PAGE and Coomassie Blue staining. Open arrowheads indicate respective proteins. Right top: EGFP-PTS1 and Pex5pS (1 ng each) were
incubated at 4°C for 1 h in the semi-intact import buffer and assessed for peroxisomal import at 26°C for 1 h using semi-intact HeLa cells as described (Mukai
et al., 2019). Cells were stained with antibodies to Pex14p (a, e, and i), GFP (b, f, and j), and β-tubulin (g and k), and DNA was stained with Hoechst 33342 (h and
l). Merged view of images stained with anti-Pex14p and anti-GFP antibodies and tubulin-stained plus Hoechst 33342–stained nuclei are shown in c and d,
respectively. Right middle and bottom: Semi-intact HeLa cells were treated with (+) or without (–) λ protein phosphatase (λ phosphatase) in phosphatase
treatment buffer containing 1 mMMnCl2. EGFP-PTS1 import assay was likewise performed as in the top panels. Solid arrowheads indicate prometaphase cells;
asterisks show interphase cells. Scale bar, 5 µm.
Figure 4. Pex5p binding to Pex14p is not altered in mitosis. (A) Coimmunoprecipitation assay using FLAG-Pex14p variants with Pex5p. WT FLAG-Pex14p
and its mutants each harboring S232A and S232D were separately expressed in pex14 HeLa cells, and cell lysates were subjected to immunoprecipitation (IP)
with anti-FLAG antibody. Input, 10% input used for IP. Immunoprecipitated proteins were analyzed by SDS-PAGE and immunoblotting using antibodies to
Pex5p (top), Pex14p (middle), and GAPDH (bottom). Arrowhead indicates Pex5p; asterisk indicates a nonspecific band. (B) The binding of endogenous Pex14p
to Pex5p in mitosis. Lysates from mitotic (M) and interphase (I) HeLa cells were subjected to IP with anti-Pex14p antibody. Input, 5% input used for im-
munoprecipitation. Immunoprecipitates were analyzed by SDS-PAGE and Phos-tag PAGE followed by immunoblotting with antibodies to Pex5p, Pex14p,
p-histone H3, and GAPDH. Arrowhead indicates Pex5p in SDS-PAGE and Pex14p in Phos-tag PAGE; asterisk indicates a nonspecific band.
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fragments compared with the SD mutant, suggesting that the
N-terminal region of the SD mutant was more resistant to the
proteinase K digestion. We interpreted the results to mean that
this region containing the coiled-coil domain shifts to a more
compact and protease-resistant configuration upon phosphoryla-
tion at S232 (Fig. 6 F). Accordingly, it is conceivable that phospho-
rylation at S232 induces a conformational change and stabilization
of Pex14p homo-oligomer via the coiled-coil domain (Fig. 6 G).
Mitotic phosphorylation protects the N-terminal region of
Pex14p from protease digestion
We likewise performed limited proteolysis analysis as in Fig. 6 F
to verify the conformational change of Pex14p in mitotic cells.
PNS fractions each from interphase and mitotic HeLa cells were
treated with proteinase K and analyzed by immunoblotting with
antibody to Pex14pN-terminal region. N-terminal region of Pex14p
from interphase cells resulted in several lower-molecular-mass
fragments, whereas that from metaphase cells was more resistant
to the partial digestion, implying that the N-terminal region of
Pex14p was converted to a more protease-resistant conformation
(Fig. 7 A, left panel). Moreover, Pex14p fragments with lower
molecularmasseswere not detectedwith antiserum specific for the
C-terminal region (Fig. 7 A, right panel, and Fig. S3). Taken to-
gether, these results suggest thatmitotic phosphorylation of Pex14p
leads to a conformational change of its C-terminal part containing
the coiled-coil domain. Moreover, it is likely that structural changes
in the C-terminal part of Pex14p translate to changes in the
N-terminal region of Pex14p, which is the part of the Pex5p-binding
domain, leading to reduced Pex5 export from the peroxisomal
matrix to the cytosol, and thereby overall suppression of peroxi-
somal matrix protein import.
Discussion
Peroxisomal matrix proteins are posttranslationally imported
into peroxisomes by a membrane-bound translocation complex
Figure 5. In vitro Pex5p import and export assays. (A) An in vitro Pex5p import assay was performed. [35S]Pex5pL was incubated with PNS fractions each
from HeLa cells at mitotic phase (M) or interphase (I). After incubation, the reaction mixtures were mock treated (lanes 1 and 4) or treated with 40 µg/ml
proteinase K for 30 min at 0°C (lanes 2, 3, 5, and 6) in the absence (–) or presence (+) of 1% Triton X-100 and were then separated to organelle (P) and cytosolic
(S) fractions by centrifugation. Proteinase K digestion was terminated, and aliquots of P fractions were analyzed by SDS-PAGE (top and bottom) and Phos-tag
PAGE (middle). [35S]Pex5pL was detected by an FLA7000 autoimaging analyzer. Pex14p was detected by immunoblotting. Solid and open arrowheads indicate
full-length and partially proteinase K-cleaved [35S]Pex5pL, respectively. In Phos-tag PAGE, solid arrowhead indicates intact Pex14p. (B) In vitro export of Pex5p.
35S-Pex5L import was performed with PNS from HeLa cells at M or I, as in A. The P fractions (A, lanes 1 and 4) were centrifuged and resuspended with the S
fraction in export buffer containing 3 mM ATP. The reaction mixtures were incubated at 26°C for 30 min and centrifuged to separate into P and S fractions.
[35S]Pex5pL in P and S fractions was separated by SDS-PAGE and detected by a Typhoon FLA 9500 autoimaging analyzer (top). Endogenous Pex14p was
separated by Phos-tag PAGE (middle) or SDS-PAGE (bottom) and detected by immunoblotting. In Phos-tag PAGE, solid arrowhead indicates intact Pex14p.
(C) Results obtained in B were represented as ratios of [35S]Pex5pL export activities. [35S]Pex5pL in S and P fractions was quantified and shown as ratios of S/
total (S plus P), n = 3. Statistical significances were verified by Student’s t test, and the significance is presented with asterisk (*, P < 0.05).
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Figure 6. Dimerization of Pex14p C-terminal domain. (A) Schematic representation of rat Pex14p variants. Numbers, amino acid residue positions of
Pex14p; light gray box, Pex5p binding domain; solid box, transmembrane domain; dark gray box, putative coiled-coil domain. S232 was substituted by A or D in
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comprising membrane peroxin Pex14p as a major component
(Barros-Barbosa et al., 2019; Itoh and Fujiki, 2006; Oliveira et al.,
2002; Otera et al., 2002; Reguenga et al., 2001). We earlier re-
ported that Pex14p forms a homodimer via the coiled-coil do-
main and interacts with Pex5p, Pex13p, and Pex19p (Itoh and
Fujiki, 2006; Tamura et al., 2014). Pex14p homo-oligomer is
likely to be involved in the assembly of pore-like structures
at the peroxisomal membrane (Meinecke et al., 2016). Here
we investigated peroxisomal protein import and its dynamics
in mitotic HeLa cells. In mitosis, Pex14p is specifically
phosphorylated at Ser-232, resulting in down-regulation of
peroxisomal protein import. The mitotic phosphorylation site of
human Pex14p, S232, fits to a consensus motif, P-X-S-P, for CDK1
and is highly conserved among vertebrates (Fig. 2 D), but not in
fly, worm, or yeast. This is the first demonstration for the reg-
ulation of peroxisome matrix protein translocation via signal
transduction pathways responding to intra- or extracellular
signals. In the present study, we show that N-terminal deletion
variants, FLAG-Pex14p(156–376) and FLAG-Pex14p(200–376),
are sufficient for homointeraction to assemble a homo-oligomer.
the truncated mutant of Pex14p, Pex14p(156–376), and Pex14p(200–376). (B) FLAG-tagged full-length Pex14p(1–376) and its variants harboring S232A (SA) or
S232D (SD) mutation were coexpressed with His-tagged Pex14p(1–376) variants in pex14 HeLa cells. Immunoprecipitates using anti-FLAG antibody were
analyzed by SDS-PAGE and immunoblotting with antibodies to His (top) and FLAG (middle). GAPDH, loading control. Input, 10% input used for immuno-
precipitation (IP). Open and solid arrowheads indicate the His-Pex14p and FLAG-Pex14p, respectively; asterisk indicates a nonspecific band. (C) Left: FLAG- and
HA-tagged Pex14p(156–376) with or without S232 mutations were assessed for homointeraction in pex14HeLa cells as in B. Immunoblotting with antibodies to
HA (top) and FLAG (middle). β-Tubulin, loading control. Input, 5% input used for IP. Right: The binding efficiency is represented as percentages of HA-tagged
Pex14p(156–376) to FLAG-tagged Pex14p(156–376). Values are the averages from two experiments. Error bars show range. (D) Left: WT Pex14p and mutant
Pex14p(156–376) were expressed in pex14 HeLa cells. Lysates from these cells were analyzed by BN-PAGE and SDS-PAGE. An oligomer was detected by
immunoblotting with anti-Pex14pC antibody (top). Immunoblot analyses with anti-Pex14pC (middle) and anti-β-tubulin (bottom) antibodies were examined to
assess loading controls. Molecular mass markers are on the left. Right: Oligomer of Pex14p(156–376) was quantified and normalized with the loaded amount in
BN-PAGE analysis. Homo-oligomerization was represented by taking as 1 that of Pex14p(156–376), and evaluated as bar graph (n = 2). Error bars showed
standard error of the averages. Statistical significance in n = 2 betweenWT and S232D was verified by ANOVA and post hoc Dunnett’s test, and the significance
is presented by asterisk (*, P < 0.05). (E) WT Pex14p and mutant Pex14p (200–376) were expressed in pex14 HeLa cells. Lysates from these cells were
separated by BN-PAGE and SDS-PAGE followed by immunoblotting as described in D. An oligomer of Pex14p (200–376) was detected (top) as in D. (F) FLAG-
Pex14p (156–376) or its variants harboring S232A or S232Dmutation was expressed in pex14 HeLa cells. PNS fractions from these cells were treated for 30 min
on ice with proteinase K at the indicated concentration. The reaction mixtures were analyzed by SDS-PAGE and immunoblotting with anti-FLAG antibody.
Open and solid arrowheads indicate the FLAG-Pex14p (156–376) and major proteinase K–digested fragments, respectively. (G) A schematic model of con-
formational change in Pex14p C-terminal region (represented as a homodimer), between interphase (I-phase) and mitotic phase (M-phase). The C-terminal
region following the transmembrane domain was presented. Shaded box, coiled-coil domain (156–197); bar, C-terminal region encompassing 200–376.
Phosphorylation at S232 suppresses the flexibility of C-terminal region and confers a conformational change of Pex14p.
Figure 7. Conformational changes of Pex14p in cell
cycle progression. (A) PNS fractions from interphase (I)
and mitotic phase (M) HeLa cells were treated for
30 min on ice with proteinase K at indicated concen-
trations. The reaction mixtures were analyzed by SDS-
PAGE and immunoblotting with antibodies to Pex14pN
(left) and Pex14pC (right). Open and solid arrowheads
indicate the endogenous Pex14p and major proteinase K–
digested fragments, respectively. The dot designates a
cleaved product of Pex14p; *, nonspecific bands. Right, solid
arrowhead indicates an unknown band. (B) Amodel for the
Pex14p conformations regulated by phosphorylation at
S232. Pex5p-cargo complexes in interphase and mitotic-
phase cells are competent for targeting to peroxisomes.
Phosphorylated Pex14p at S232 in mitotic cells shows rel-
atively compact and less flexibility. This conformational
change potentially suppresses themobility of Pex5p-binding
domain at N-terminal region of Pex14p, thereby giving rise
to the retardation of Pex5p recycling in mitotic cells.
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It is more likely that the C-terminal part of Pex14p possesses
several homomerically interacting domains as well as the coiled-
coil domain and undergoes conformational change by mitotic
phosphorylation, resulting in an increase of homomeric-
interacting affinity. Recently, Pex14p was suggested to expose
its N-terminal domain into the organelle matrix (Barros-
Barbosa et al., 2019). Accordingly, it is possible that the
protease-sensitive form exposing its Pex5p binding domain to
cytosol is responsible for the step of Pex5p recycling in inter-
phase cells. In this study, we verified the involvement of mi-
totic Pex14p phosphorylation in the export step of Pex5p.
Intriguingly, we revealed that peroxisomes from interphase
cells are competent to export Pex5p into the cytosol, whereas
mitotic peroxisomes barely export Pex5p. These findings suggest
that mitotic phosphorylation of Pex14p suppresses the topological
change of the N-terminal part, resulting in the down-regulation of
Pex5p export. The question to be addressed is how the phospho-
rylation of the Pex14p C-terminal part leads to a stabilization of
homo-oligomer and suppression of the Pex5p export step. The
mechanistic roles of phosphorylation in the peroxin–peroxin in-
teraction and Pex5p export reaction remain to be defined.
Synchronization of cytoplasmic and nuclear events is tem-
porally and spatially regulated by CDK1 during G2/M progres-
sion (Barnes et al., 2001). The nuclear envelope and Golgi
apparatus are disassembled in early mitotic phase and then re-
constructed at a late stage of mitosis (Smoyer and Jaspersen,
2014). Soluble factors including p97 and p47 involved in Golgi
assembly are phosphorylated during mitosis and promote mi-
totic Golgi disassembly. Furthermore, dynamin-related GTPase,
Drp1, is phosphorylated by CDK1, which stimulates mitochon-
drial fission in mitosis (Taguchi et al., 2007). Several assembly
factors of Golgi apparatus and mitochondria such as p47 and
Tom6, respectively, are phosphorylated and regulated in mitosis
for cell cycle progression (Uchiyama et al., 2003; Harbauer et al.,
2014). It is reasonable to speculate that mitosis-specific func-
tions such as chromosome separation and cytokinesis are se-
lected and prioritized, whereas peroxisomal protein transport
and metabolic functions are suppressed by the phosphorylation
of Pex14p. An elevated level of Pex5p associated with Pex14p is
detectable under ATP-limiting conditions, and ATP depletion
fails to export Pex5p from peroxisomes (Miyata and Fujiki,
2005; Platta et al., 2005). In the present study, Pex5p export
was indeed significantly lowered in mitotic peroxisomes, sug-
gesting that peroxisomal protein import is down-regulated and
suppressed in order not to consume ATP (Fig. 5 B).
We recently reported that a portion of catalase is localized to
the cytosol at steady state in WT CHO-K1 cells, suggesting that
cytosolic catalase could more efficiently eliminate oxidative
stress than peroxisomal catalase (Hosoi et al., 2017). The mitotic
phosphorylation of Pex14p suppresses peroxisomal import, re-
sulting in a lower efficiency of catalase import to peroxisomes
compared with that of the other matrix proteins, including PTS1
proteins (Fig. 3, A and B). In mitotic cells, the inefficient import
of catalase to peroxisomes would increase cytosolic catalase,
which eliminates the cytosolic reactive oxygen species including
H2O2. DNA is thought to be fragile and sensitive to oxidative
stress, such as hydrogen peroxide, especially in mitosis, in
which the nuclear envelope disappears. A reduced level of cy-
tosolic catalase inmitosis might increase the risk of DNA damage
from hydrogen peroxide. Dubreuil et al. (2020) recently re-
ported that cytosolically localized catalase is the most protective
in cells against the treatment with H2O2, implying that the lo-
calization of catalase in the cells determines its efficiency in
ameliorating oxidative stress. Moreover, cell cycle–dependent
phosphorylation of Pex14p may also be involved in the regula-
tion of peroxisomal assembly and metabolic function in em-
bryonic development with rapid and intense cell division.
Here we propose a model for the role of mitotic phospho-
rylation of Pex14p in peroxisomal matrix protein import. The
Pex5p–cargo protein complex targets to peroxisomes through its
binding to the docking complex containing Pex14p. Pex5p is
competent to interact with unphosphorylated and phosphory-
lated Pex14p. In nonmitotic cells, cargo proteins are unloaded from
Pex5p inside or at the surface of peroxisomes, and conformational
change of Pex14p more likely leads to Pex5p release from Pex14p
and its export from peroxisomes. On the other hand, in mitotic
cells, S232 phosphorylation of Pex14p prevents topological change
of the N-terminal part of Pex14p, resulting in the suppression of
Pex5p export and peroxisomal matrix protein import.
Materials and methods
Antibodies
We used guinea pig antisera to C-terminal region of rat Pex14p,
termed Pex14pC (Mukai et al., 2002), and rabbit antisera to
N-terminal part of rat Pex14p, named Pex14pN (Shimizu et al.,
1999), as well as Pex14pC (Shimizu et al., 1999), PTS1 peptide
(Otera et al., 2002), human catalase (Matsumoto et al., 2003),
Pex13pSH3 (Mukai and Fujiki, 2006), and Pex5p (Okumoto
et al., 2011). Rabbit antibodies to FLAG (F7425) and β-tubulin
were purchased from Sigma-Aldrich; rabbit anti-GFP was from
MBL; rabbit monoclonal antibody to CDK1 was from Abcam; mouse
antibody to phospho-histone H3 (Ser10; D2C8) was from Cell Sig-
naling Technology; mouse antibody to GAPDH (3E12) was from
Bioss; mouse antibody to HA (16B12) was from Covance; and mouse
antibody to His6 (34660) was from Qiagen. For immunoprecipita-
tion, we used mouse anti-Flag M2 agarose (Sigma-Aldrich).
Cell culture, DNA transfection, and cell synchronization
HeLa cells were cultured in DMEM supplemented with 10% FCS
under 5% CO2 at 37°C as described (Okumoto et al., 2011). CHO
cells were cultured in Ham’s F-12 medium supplemented with
10% FCS under 5% CO2 at 37°C as described (Tsukamoto et al.,
1990). DNA transfection was performed using Lipofectamine
2000 (Invitrogen) and by electroporation (NEPA21 Super Elec-
troporator; Neppa Gene) as recommended by the manufacturer.
Mitotic arrest was performed with 50 ng/ml nocodazole for
12–18 h, and mitotic cells were collected by mitotic shake-off.
Adherent cells after shake-off were collected as interphase cells.
LC-MS/MS–based identification of Pex14p phosphorylation
sites
Mitotic and interphase HeLa cells were collected by centrifu-
gation at 750 g for 5 min. Radioimmunoprecipitation assay
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buffer (50 mM Tris-HCl, 0.15 M NaCl, 0.1% wt/vol SDS, 0.5%
wt/vol sodium deoxycholate, and 1% wt/vol Nonidet P-40)
supplemented with protease inhibitor cocktail complete EDTA-
free (Roche) was added to the pellet. After pipetting several
times, the cell pellets were lysed on ice for 10 min. After cen-
trifugation at 12,000 g for 10 min, the collected supernatants
were incubated with antibody to Pex14pN that was immobi-
lized on SureBeads Protein G magnetic beads (Bio-Rad) for 3 h
at 4°C with rotation. The beads were washed four times with
radioimmunoprecipitation assay buffer and then twice with
50 mM ammonium bicarbonate. Proteins on the beads were
digested with 400 ng of trypsin/Lys-C mix (Promega) for 16 h at
37°C. The digests were acidified and desalted using GL-Tip SDS
(GL Sciences). The eluates were evaporated and dissolved in 3%
acetonitrile (ACN) and 0.1% trifluoroacetic acid.
LC-MS/MS analysis of the resultant peptides was performed
on an EASY-nLC 1200 UHPLC connected to a Q Exactive Plus
mass spectrometer equipped with a nanoelectrospray ion source
(Thermo Fisher Scientific). The peptides were separated on a 75-
µm inner diameter × 150mmC18 reverse-phase column (Nikkyo
Technos) with a liner 4–28% ACN gradient for 0–100 min fol-
lowed by an increase to 80% ACN for 10 min. The mass spec-
trometer was operated in data-dependent acquisition mode with
a top 10 MS/MS method. MS1 spectra were measured with a
resolution of 70,000, an automatic gain control target of 106, and
a mass range from 350 to 1,500 m/z. High-energy collisional
dissociation MS/MS spectra were acquired at a resolution of
17,500, an automatic gain control target of 5 × 104, an isolation
window of 2.0 m/z, a maximum injection time of 60 ms, and a
normalized collision energy of 27. Dynamic exclusion was set to
10 s. Raw data were directly analyzed against the SwissProt
database restricted to Homo sapiens using Proteome Discoverer
v2.3 (Thermo Fisher Scientific) with Mascot search engine v2.5
(Matrix Science) for identification and label-free precursor ion
quantification. The search parameters were as follows: (a) trypsin
as an enzymewith up to twomissed cleavages; (b) precursor mass
tolerance of 10 ppm; (c) fragment mass tolerance of 0.02 D; (d)
carbamidomethylation of cysteine as a fixed modification; and (e)
acetylation of the protein N-terminus, oxidation of methionine,
and phosphorylation of serine, threonine, and tyrosine as variable
modifications. Peptides were filtered at a false discovery rate of 1%
using the percolator node. Normalizationwas performed such that
the total sum of abundance values for each sample over all pep-
tides was the same.
Treatment with λ protein phosphatase and CDK1 inhibitor
Cell lysates and semi-intact cells were treated at 30°C for 30 min
with λ protein phosphatase (8 units/µl; New England Biolabs) in
phosphatase treatment buffer containing 1 mM MnCl2. For treat-
ment with CDK1 inhibitor, synchronized mitotic HeLa cells were
collected, washed with PBS, and cultured for 0–60 min in the
presence of 9 µM RO-3306 (Vassilev et al., 2006), CDK1 inhibitor.
siRNA transfection
Knockdown of CDK1 in HeLa cells was performed by transfection of
MISSION siRNA (Sigma-Aldrich) with Lipofectamine 2000, ac-
cording to the manufacturer’s instructions. The sequence of siRNA
for human CDK1 was 59-GGCUUGGAUUUGCUCUCGA(dT)(dT)-39.
MISSION siRNA Universal Negative Control (Sigma-Aldrich) was
used as a control.
Generation of pex14 HeLa cell line using the CRISPR/Cas-9
system
To generate pex14 HeLa cell line, we used gRNA specific for
human PEX14 (Ran et al., 2013). The target sequence of gRNAwas
selected using an online CRISPR design tool (MIT, Cambridge,
MA). To construct the plasmid coexpressing Cas9 and
PEX14gRNA, a pair of oligonucleotides containing the gRNA target
sequence was annealed and ligated into the BbsI-linearized pX330
vector (Addgene; Yagita et al., 2017). The pair of oligonucleotides
used were 59-CACCGCTGTAGAAACTTCACTGCCG-39 and 59-AAA
CCGGCAGTGAAGTTTCTACAGC-39 for PEX14 gRNA. The resultant
plasmid, pX330/PEX14gRNA, was transfected to HeLa cells.
Transfected cells were diluted and screened for Pex14p deficiency
by immunofluorescence microscopy and immunoblotting. One
clonal pex14 HeLa cell line was used in this study.
DNA construction
A plasmid encoding N-terminally FLAG-tagged rat Pex14p cDNA
(Shimizu et al., 1999) was inserted into pcDNA3.1/Zeo (In-
vitrogen). By using an inverse PCR method (Dominy and
Andrews, 2003), the last 45 bp of cytomegalovirus promoter/
enhancer region of pcDNA3.1/Zeo was deleted to suppress the
overexpression of Pex14p. PEX14 mutants harboring point muta-
tions were also generated by inverse PCR. To construct plasmids,
PEX14(156–376) and PEX14(200-376), BglII and XbaI fragments
each encoding Pex14p(156–376) and Pex14p(200–376) that were
N-terminally fused with FLAG or HA were PCR amplified and li-
gated into the BamHI/XbaI sites of pcDNA3.1/Zeo.
Morphological analysis
Cells were fixed with 4% PFA, permeabilized with 0.1% Triton X-
100 containing 1% BSA (Otera et al., 2002), and incubated with
antibodies at RT for 1 h. Rabbit antibodies against PTS1 peptide
(Otera et al., 2002), human catalase (Matsumoto et al., 2003),
and GFP (Mukai et al., 2019) and guinea pig antibody against
Pex14pC (Mukai et al., 2002) were used as primary antibodies.
Indirect immunofluorescent staining using secondary antibodies
labeled with Alexa Fluor 488 and 568 (Invitrogen) was per-
formed as described (Tamura et al., 2014). Cells were observed
on a Zeiss Axioscop with a Plan Apochromat 63× 1.4-NA oil ob-
jective lens. In Fig. 3 C, confocal fluorescence microscopy was
performed on a Zeiss LSM510 with Axio Observer.Z1 equipped
with a Plan Apochromat 100× 1.4-NA oil objective lens and argon
plus dual HeNe lasers at RT. Images were acquired with Zen
software (Zeiss) and prepared using Photoshop (CS4; Adobe).
Peroxisome-restoring activity of the S232 and S334 mutants of
Pex14p was verified by counting PTS1- or catalase-positive cells
among 100 cells expressing Pex14p and its variants in pex14HeLa
cells. The import efficiency of WT Pex14p was taken as 100%.
Coimmunoprecipitation assay
HeLa cells were lysed with lysis buffer containing 50 mM Tris-
HCl, pH 7.4, 10% glycerol, 0.15 M NaCl, 1% Triton X-100, 1 mM
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PMSF, 1 mM EDTA, 1 mM DTT, 25 µg/ml each of antipain and
leupeptin, and 50 units of aprotinin (Sigma-Aldrich). Pex14p was
immunoprecipitated with rabbit antibody to Pex14pC conjugated to
Protein-A-Sepharose (GE Healthcare). pex14 HeLa cells were trans-
fectedwith normal ormutant FLAG-PEX14 andHA-PEX14. Cells were
directly lysed with the lysis buffer. FLAG-Pex14p and its variants
were immunoprecipitated using agarose beads conjugated with
anti-FLAG antibody (M2; Sigma-Aldrich). The immunocomplexes
were analyzed by SDS-PAGE and immunoblotting.
In vitro peroxisomal Pex5p import and export assays
Assays for import of Pex5p was performed as follows. A PNS
fraction was prepared from mitotic and interphase HeLa cells.
These cells (5 × 106 each) were homogenized with import buffer
containing 0.25 M sucrose, 5 mM Hepes-KOH, pH 7.4, 3 mM
MgCl2, 50 mM KCl, and 1 mM DTT. The PNS fraction was ob-
tained by centrifuging the homogenate at 800 g for 5 min.
Pex5pL was used in peroxisomal import and export assays.
Pex5pL cDNA was transcribed and translated using TNT Quick
Coupled transcription/translation systems (Promega) with [35S]
methionine and [35S]cysteine (Amersham Biosciences) to generate
35S-labeled Pex5pL (Miyata et al., 2009). The import reactionmixture
(100 µl) containing [35S]Pex5pL and 5 mg/ml PNS was incubated at
26°C for 1 h. Import of [35S]Pex5pL was verified by its resistance to
the treatment with externally added protease in the absence or
presence of 1% Triton X-100 as follows. The import reaction mixture
was incubated on ice for 30 min with 40 µg/ml proteinase K. After
terminating the protease digestion with 1 mM PMSF, the assay
mixturewas centrifuged at 20,000 g for 20min to separate organelle
and cytosolic fractions and analyzed by SDS-PAGE, autoradiography,
and immunoblotting. [35S]Pex5pL was detected by a Typhoon FLA
9500 autoimaging analyzer (GE Healthcare).
For Pex5p export reaction, the PNS fraction incubated with
[35S]Pex5pL in the import buffer was centrifuged at 20,000 g for
20 min to isolate the organelle fraction containing the [35S]
Pex5pL-imported peroxisomes. The organelle fraction was re-
suspended with the cytosolic fraction (1 mg/ml) from mitotic or
interphase HeLa cells in export buffer, 5 mM Hepes-KOH, pH
7.4, 3 mM MgCl2, 50 mM KCl, 1 mM DTT, 4% (vol/vol) rabbit
reticulocyte lysate, and 3 mM ATP (Miyata et al., 2009). After
the export reaction at 26°C for 1 h, the assay mixture was sep-
arated into organelle and cytosolic fractions by centrifugation at
20,000 g for 20 min. [35S]Pex5pL was detected as above.
Protease digestion assay
PNS fractions were prepared from mitotic and interphase HeLa
cells or pex14 HeLa cells transfected with PEX14, PEX14S232A, or
PEX14S232D. Partial protease-treatment experiments using 0.5mg/
ml of PNS fraction from HeLa cells with 2.5–30 µg/ml proteinase
Kwere performed on ice for 30min. The digestionwas terminated
by the addition of 1 mM PMSF. The digests were analyzed by SDS-
PAGE and immunoblotting with rabbit antibodies to Pex14pN and
Pex14pC.
Other methods
Immunoblotting was performed using electrophoretically trans-
ferred samples on polyvinylidene membranes (Bio-Rad) with
primary antibodies and secondary antibodies conjugated to HRP
(GE Healthsciences; Otera et al., 2002). Antigen–antibody com-
plexes were visualized with an ECL Western blotting detection
reagent (GE Healthsciences). BN-PAGE analysis was done using
4–16% Bis-Tris Gel (Invitrogen) as described (Tamura et al., 2014).
For Phos-tag PAGE analysis, 50 µM MnCl2 and 25 µM Phos-tag
acrylamide (Wako) were added to acrylamide gel before making
gel of SDS-PAGE (Kinoshita et al., 2006).
Online supplemental material
Fig. S1 shows that mutation of Ser232 to Ala appeared to induce
additional mitotic phosphorylation of rat Pex14p at Ser247. Fig. S2
shows that the import efficiency of a dual mutant Pex14pS232D/
S334D was similar to that of S232D, suggesting that S232 is an
important phosphorylation site in the regulation of peroxisomal
protein import during mitosis. Fig. S3 shows that the specificities
of antibodies to Pex14p N- or C-terminal region.
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Supplemental material
Figure S1. Phos-tag PAGE analysis of WT Pex14p and its mutants. Four potential phosphorylation sites of Pex14p were substituted to Ala, two of which
are shown in Fig. 2 E (upper panels). Pex14p mutants with two-site mutations were likewise analyzed (lower panels). M, mitotic-phase cells; I, interphase cells.
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Figure S2. Phosphomimetic Pex14p suppresses peroxisomal import of matrix proteins. Pex14p variants mutated at both S232 and S334 were assessed
for peroxisomal protein import in pex14 HeLa cells as in Fig. 3 (A and B). Error bars show SEM. Statistical significance was verified by ANOVA and post hoc
Dunnett’s test, and the significance is indicated with asterisk (*, P < 0.001, n = 4).
Figure S3. PNS fractions from control HeLa (–) and pex14 HeLa cells were analyzed by SDS-PAGE and immunoblotting with antibodies to Pex14pN
(left) and Pex14pC (right). Open arrowheads indicate the endogenous Pex14p. The dot designates a cleaved product of Pex14p; *, nonspecific bands.
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